Farnoosh Nik‐Ahd

About

Farnoosh Nik‐Ahd is a leading researcher in the safety and outcomes of robotic urologic surgery. Her work critically examines the real-world implications of the rapid adoption of robotic platforms, particularly the da Vinci Surgical System. Her major contributions include landmark studies analyzing litigation trends and adverse events reported to the FDA over the last decade, revealing critical insights into patient safety and surgical risk. Her most cited paper, "Robotic urologic surgery: trends in litigation over the last decade," has garnered 26 citations, while her follow-up study on FDA-reported adverse events has 19 citations, collectively shaping the discourse on regulatory oversight. She has also investigated surgical outcomes in specific populations, such as obese men undergoing radical prostatectomy, comparing robotic versus retropubic approaches to limit positive surgical margins. Her work on robotic sacrocolpopexy further extends her impact into female pelvic reconstructive surgery. Through her rigorous analysis of large-scale data, Nik‐Ahd has become a key voice in evidence-based robotic surgery, helping surgeons and policymakers navigate the balance between technological innovation and patient safety.

Research Focus

Key Achievements

Top Papers

1. 1
   Robotic urologic surgery: trends in litigation over the last decade

   26 citations · 2019
2. 2
   Robotic Urologic Surgery: Trends in Food and Drug Administration-Reported Adverse Events Over the Last Decade

   19 citations · 2019
3. 3
   Obese men undergoing radical prostatectomy: Is robotic or retropubic better to limit positive surgical margins? Results from SEARCH

   10 citations · 2020
4. 4
   Robotic sacrocolpopexy: adverse events reported to the FDA over the last decade

   9 citations · 2019

Key Collaborators

Contact & Links